Unknown

Dataset Information

0

Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.


ABSTRACT: Identification of relevant epitopes is crucial for the development of subunit peptide vaccines inducing neutralizing and cellular immunity against SARS-CoV-2. Our aim was the characterization of epitopes in the receptor-binding domain (RBD) of SARS-CoV-2 spike (S) protein to generate a peptide vaccine. Epitope mapping using a panel of 10 amino acid overlapped 15-mer peptides covering region 401-515 from RBD did not identify linear epitopes when tested with sera from infected individuals or from RBD-immunized mice. However, immunization of mice with these 15-mer peptides identified four peptides located at region 446-480 that induced antibodies recognizing the peptides and RBD/S1 proteins. Immunization with peptide 446-480 from S protein formulated with Freund's adjuvant or with CpG oligodeoxinucleotide/Alum induced polyepitopic antibody responses in BALB/c and C56BL/6J mice, recognizing RBD (titres of 3 × 104-3 × 105, depending on the adjuvant) and displaying neutralizing capacity (80-95% inhibition capacity; p <0.05) against SARS-CoV-2. Murine CD4 and CD8T-cell epitopes were identified in region 446-480 and vaccination experiments using HLA transgenic mice suggested the presence of multiple human T-cell epitopes. Antibodies induced by peptide 446-480 showed broad recognition of S proteins and S-derived peptides belonging to SARS-CoV-2 variants of concern. Importantly, vaccination with peptide 446-480 or with a cyclic version of peptide 446-488 containing a disulphide bridge between cysteines 480 and 488, protected humanized K18-hACE2 mice from a lethal dose of SARS-CoV-2 (62.5 and 75% of protection; p <0.01 and p <0.001, respectively). This region could be the basis for a peptide vaccine or other vaccine platforms against Covid-19.

SUBMITTER: Aparicio B 

PROVIDER: S-EPMC8480813 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.

Aparicio Belén B   Casares Noelia N   Egea Josune J   Ruiz Marta M   Llopiz Diana D   Maestro Sheila S   Olagüe Cristina C   González-Aseguinolaza Gloria G   Smerdou Cristian C   López-Díaz de Cerio Ascensión A   Inogés Susana S   Prósper Felipe F   Yuste José R JR   Carmona-Torre Francisco F   Reina Gabriel G   Lasarte Juan J JJ   Sarobe Pablo P  

Emerging microbes & infections 20211201 1


Identification of relevant epitopes is crucial for the development of subunit peptide vaccines inducing neutralizing and cellular immunity against SARS-CoV-2. Our aim was the characterization of epitopes in the receptor-binding domain (RBD) of SARS-CoV-2 spike (S) protein to generate a peptide vaccine. Epitope mapping using a panel of 10 amino acid overlapped 15-mer peptides covering region 401-515 from RBD did not identify linear epitopes when tested with sera from infected individuals or from  ...[more]

Similar Datasets

| S-EPMC8055925 | biostudies-literature
| S-EPMC11322561 | biostudies-literature
| S-EPMC4885088 | biostudies-literature
| S-EPMC9538582 | biostudies-literature
| S-EPMC3100770 | biostudies-literature
| S-EPMC6833294 | biostudies-literature
| S-EPMC3077947 | biostudies-literature
| S-EPMC10616275 | biostudies-literature
| S-EPMC9452889 | biostudies-literature
| S-EPMC129356 | biostudies-literature